ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infec...
CEC Capital advises Zhongkexinyang on 100-million-yuan private financing round
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
C&Y Pharmaceutical: Net profit in the third quarter was 21.9466 million yuan, a year-on-year increase of 106.06%
C&Y Pharmaceutical shareholder Weng Zhanguo plans to reduce his holdings by no more than 3%
C&Y Pharmaceutical: Launching a financing lease sale-leaseback business not exceeding 50 million yuan
The hepatitis concept sector has seen a short-term surge